Previous 10 | Next 10 |
--News Direct-- In a recent article for Boston Business Journal , our head of Medical Affairs, Dr. Kanchan Relwani highlights the importance of patient-focused drug development and how we seek to incorporate the patient voice into all we do. About Alkermes Alkermes plc i...
Alkermes Commences Arbitration Related to License Agreements with Janssen Pharmaceutica PR Newswire DUBLIN , April 19, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it commenced binding arbitration proceedings in respect ...
Alkermes is a publicly-traded company that offers biopharmaceutical products and technology. The company has seen a reduction in losses in the past few years and is making steady progress towards generating profit. Recent financial trends indicate that 2022 should see a recovery a...
Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society PR Newswire – Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI ® in Patients Early in Illness –...
Baker Brothers’ 13F portfolio value decreased from $22.77B to $20.55B this quarter. Incyte and Legend Biotech stakes were increased this quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~63% of the portfolio. For f...
--News Direct-- As we approach the second anniversary of the COVID-19 pandemic, our Head of Human Resources, Steve Schiavo, took time to reflect on the appreciation we have for all our employees – especially those in key business areas, including research, development, manufactur...
--News Direct-- March marks women's history month , a time for us to celebrate the work women have done to improve how we understand and treat mental illness . Click the images above to learn more about several mental health pioneers. Alkermes Alkermes plc is a fully...
The following slide deck was published by Alkermes plc in conjunction with this event. For further details see: Alkermes (ALKS) Investor Presentaion - Slideshow
Alkermes to Participate in the Stifel 2022 CNS Days PR Newswire DUBLIN , March 22, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops , will participate in a fireside chat at the Sti...
--News Direct-- Our recent survey conducted with The Harris Poll and Depression and Bipolar Support Alliance – National Headquarters found that sleep quality is a top concern among the adults with bipolar I disorder who participated in the survey. This Sleep Awarene...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...